Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
INMD · against 1,372 other Healthcare companies
Ranked #310 of 1,373 · scores higher than 77% of peers · safety percentile 77
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 70–79, including INMD · Click a bar to see the companies
Mainly thanks to its debt / equity and current ratio, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | INMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.01× | 0.24× | 92% | 33% | |
| BetaLower is better · 1,320 reported | 1.86 | 0.53 | 6% | 33% | |
| Current ratioHigher is better · 1,338 reported | 8.18× | 2.62× | 84% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 306 | 7.1B CNY (≈$993M) | 78 | 27 | |
| 307 | 6.2B USD | 78 | 44 | |
| 308 | 13.2B CNY (≈$1.8B) | 78 | 71 | |
| 309 | 1.9B USD | 78 | 68 | |
| 310 | 810M USD | 77 | 69 | |
| 311 | 10.5B CNY (≈$1.5B) | 77 | 66 | |
| 312 | 5M USD | 77 | 27 | |
| 313 | 81.4B CNY (≈$11.4B) | 77 | 55 | |
| 314 | 11.2B CNY (≈$1.6B) | 77 | 61 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score